Chiasma was acquired by Amryt Pharma on August 5, 2021. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma
| Website | https://amrytpharma.com/ |
| Ticker | CHMA |
| Revenue | $233.2 million |
| Employees | 18 (5 on RocketReach) |
| Founded | 2001 |
| Phone | (914) 234-2268 |
| Fax | (781) 207-2432 |
| Industry | Biotechnology Research, Manufacturing General, Biopharma, Manufacturing, Biotechnology, Health Care, Science and Engineering, Therapeutics |
| Web Rank | 6 Million |
| Keywords | Orphan Drugs, Orphan Drug Development, Biopharmaceutical, Innovative Therapies, New Treatments, Pharmaceutical Research, Drug Development, Patient Care, Healthcare, Clinical Trials, Medical Research, Biotechnology, Drug Discovery, Life Sciences, Health Solutions, Medical Innovation, Pharmaceutical |
| Competitors | Pfizer, Amgen, Bristol Myers Squibb, Teva Pharmaceuticals, Novartis, Genentech, Sandoz, Merck AH, Mylan Belgium, Lilly India +37 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Chiasma employee's phone or email?
The Chiasma annual revenue was $233.2 million in 2026.
5 people are employed at Chiasma.
The NAICS codes for Chiasma are [3254, 32541, 325414, 325, 32].
The SIC codes for Chiasma are [28, 283].